Bufexamac is a frequent contact sensitizer

Contact Dermatitis

Volumn 34, Issue 1, 1996, Pages 63-64

  Kranke B ^a   Derhaschnig, J ^a   Komericki, P ^a   Aberer, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Allergic contact dermatitis; Bufexamac; Medicaments; Non steroidal anti inflammatory drugs; Parfenac

Indexed keywords

BUFEXAMAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTACT DERMATITIS; ERYTHEMA MULTIFORME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT; SKIN ALLERGY; SKIN SENSITIZATION;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS; BUFEXAMAC; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATCH TESTS; RETROSPECTIVE STUDIES;

EID: 0030058653     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1996.tb02118.x     Document Type: Article

References (15)

1. Achten G, Bourlond A, Haven E, Lapièere C M, Piérard J, Reynars H. Étude du bufexamac crème et du bufexamac onguent dans le traitement de diverses dermatoses. Dermatologica 1973: 146: 1-7.
2. Mackey J P. A double-blind clinical study of bufexamac and fluocinolone acetonide in dermatitis. J Irish Med Assoc 1974: 67: 214-216.
3. Stüttgen G. Integrierung eines nicht-steroidalen antiphlogistischen Externums in die Therapieprogrammierung. Therupiewoche 1983: 33: 3275-3277.
4. Christiansen J V, Gadborg E, Kleiter I, Ludvigsen K, Meier C H K, Norholm A, Reiter H, Reymann F, Raaschou-Nielsen W, Sondergaard M, Unna P, Wehnert R. Efficacy of bufexamac (NFN) cream in skin diseases. Dermatologica 1977: 154: 177-184.
5. Smeenk G. Contact allergy to bufexamac. Dermatologica 1973: 147: 334-337.
6. Van Hecke E. Allergy to bufexamac. Arch Belg Dermatol 1973: 29: 301-303.
7. Koch P, Bahmer F A. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases. Contact Dermatitis 1994: 31: 97-101.
8. Frosch P J, Raulin C. Kontaktallergie auf Bufexamac. Hautarzt 1987: 38: 331-334.
9. Tada J, Toi Y, Arata J. Atopic dermatitis with severe facial lesions exacerbated by contact dermatitis from topical medicaments. Contact Dermatitis 1994: 31: 261-263.
10. Lachapelle J M. Contact sensitivity to bufexamac. Contact Dermatitis 1975: 1: 261.
11. Meneghini C L, Angelini G. Contact allergy to antirheumatic drugs. Contact Dermatitis 1979: 5: 197-198.
12. Reiffers J. Contact dermatitis to bufexamac. Dermatologica 1982: 164: 354-356.
13. Perret C M, Happle R. Contact allergy to bufexamac. Contact Dermatitis 1989: 20: 307-308.
14. Wein S, Blecher P, Ruzicka T. Die Rolle der Atopie in der Pathogenese des Analekzems. Z Hautkr 1994: 69: 113-119.
15. Anonymus. Kontaktallergie gegen Bufexamac. Dermatosen 1993: 41: 214.